|
 
Vaccine-Associated Feline Sarcoma Task Force Sponsors
Contributions to the Task Force have totaled $903,478
to fund research into the incidence, causes, and treatment of feline sarcoma.
Total Study Funding
| Organizations |
$344,500 |
| |
| Industry |
$557,500 |
| |
| Individuals |
$1,478 |
| Organizations |
| |
| American Animal Hospital Association |
$117,000* |
| |
| American Association of Feline Practitioners |
$95,000 |
| |
| American Veterinary Medical Association |
$50,000 |
| |
| Cornell Feline Health Center |
$50,000 |
| |
| Veterinary Cancer Society |
$27,500 |
| |
| Ohio Veterinary Medical Association |
$5,000 |
|
| * (plus expenses of VAFSTF Roundtable) |
| Industry (Manufacturers) |
| |
| Pfizer Animal Health |
$250,000 |
| |
| Fort Dodge Animal Health |
$100,000 |
| |
| Novartis |
$70,000 |
| |
| Intervet |
$40,000 |
| |
| Schering-Plough |
$40,000 |
| |
| Merial |
$30,000 |
| |
| Biocor Animal Health |
$15,000 |
| |
| Bayer Animal Health |
$10,000 |
| |
| Synbiotics |
$2,500 |
|
 Top
|
